| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2524498 | Biomedicine & Pharmacotherapy | 2012 | 5 Pages |
Abstract
A reduction in CNI dosage may lead to a decrease in the occurrence of post-transplant malignancy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yaacov Ori, Michal Herman-Edelstein, Boris Zingerman, Benaya Rozen-Zvi, Uzi Gafter, Tsipora Malachi, Anat Gafter-Gvili,